SUMMIT RHEUMATOLOGY Trademark

Trademark Overview


On Thursday, August 28, 2025, a trademark application was filed for SUMMIT RHEUMATOLOGY with the United States Patent and Trademark Office. The USPTO has given the SUMMIT RHEUMATOLOGY trademark a serial number of 99363741. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, February 9, 2026. This trademark is owned by Optum, Inc.. The SUMMIT RHEUMATOLOGY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Healthcare
summit rheumatology

General Information


Serial Number99363741
Word MarkSUMMIT RHEUMATOLOGY
Filing DateThursday, August 28, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, February 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2026

Trademark Statements


NOT AVAILABLE"RHEUMATOLOGY"
Goods and ServicesHealthcare

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 28, 2025
Primary Code044
First Use Anywhere DateTuesday, January 31, 2023
First Use In Commerce DateTuesday, January 31, 2023

Trademark Owner History


Party NameOptum, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEden Prairie, MN 55344

Trademark Events


Event DateEvent Description
Thursday, August 28, 2025NEW APPLICATION ENTERED
Thursday, August 28, 2025APPLICATION FILING RECEIPT MAILED
Sunday, January 18, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 20, 2026ASSIGNED TO EXAMINER
Friday, January 30, 2026EXAMINERS AMENDMENT -WRITTEN
Friday, January 30, 2026EXAMINERS AMENDMENT E-MAILED
Friday, January 30, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 30, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, February 3, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords


rheumatology summit healthcare